Integrative Neuroscience Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
The Scripps Research Institute, La Jolla, CA, USA.
Pharmacol Biochem Behav. 2021 May;204:173155. doi: 10.1016/j.pbb.2021.173155. Epub 2021 Feb 23.
Alcohol tolerance refers to a lower effect of alcohol with repeated exposure. Although alcohol tolerance has been historically included in diagnostic manuals as one of the key criteria for a diagnosis of alcohol use disorder (AUD), understanding its neurobiological mechanisms has been neglected in preclinical studies. In this mini-review, we provide a theoretical framework for alcohol tolerance. We then briefly describe chronic tolerance, followed by a longer discussion of behavioral and neurobiological aspects that underlie rapid tolerance in rodent models. Glutamate/nitric oxide, γ-aminobutyric acid, opioids, serotonin, dopamine, adenosine, cannabinoids, norepinephrine, vasopressin, neuropeptide Y, neurosteroids, and protein kinase C all modulate rapid tolerance. Most studies have evaluated the ability of pharmacological manipulations to block the development of rapid tolerance, but only a few studies have assessed their ability to reverse already established tolerance. Notably, only a few studies analyzed sex differences. Neglected areas of study include the incorporation of a key element of tolerance that involves opponent process-like neuroadaptations. Compared with alcohol drinking models, models of rapid tolerance are relatively shorter in duration and are temporally defined, which make them suitable for combining with a wide range of classic and modern research tools, such as pharmacology, optogenetics, calcium imaging, in vivo electrophysiology, and DREADDs, for in-depth studies of tolerance. We conclude that studies of the neurobiology of alcohol tolerance should be revisited with modern conceptualizations of addiction and modern neurobiological tools. This may contribute to our understanding of AUD and uncover potential targets that can attenuate hazardous alcohol drinking.
酒精耐受是指在反复接触酒精后,酒精的作用降低。尽管在历史上,酒精耐受已被纳入诊断手册,作为酒精使用障碍(AUD)诊断的关键标准之一,但在临床前研究中,其神经生物学机制一直被忽视。在这篇迷你综述中,我们为酒精耐受提供了一个理论框架。然后我们简要描述了慢性耐受,接着更详细地讨论了在啮齿动物模型中快速耐受的行为和神经生物学方面。谷氨酸/一氧化氮、γ-氨基丁酸、阿片类物质、血清素、多巴胺、腺苷、大麻素、去甲肾上腺素、血管加压素、神经肽 Y、神经甾体和蛋白激酶 C 都调节快速耐受。大多数研究都评估了药理学干预阻断快速耐受发展的能力,但只有少数研究评估了它们逆转已经建立的耐受的能力。值得注意的是,只有少数研究分析了性别差异。被忽视的研究领域包括涉及对抗性过程样神经适应的耐受的一个关键要素。与酒精摄入模型相比,快速耐受模型的持续时间相对较短,并且在时间上是定义明确的,这使得它们适合与广泛的经典和现代研究工具相结合,如药理学、光遗传学、钙成像、体内电生理学和 DREADDs,用于深入研究耐受。我们得出结论,应该用现代成瘾概念和现代神经生物学工具来重新研究酒精耐受的神经生物学。这可能有助于我们理解 AUD,并发现潜在的靶点,以减轻危险的饮酒行为。